Literature DB >> 937460

Increased intraocular pressure induced by repository corticosteroids.

J Herschler.   

Abstract

Twelve patients (14 eyes) had intraocular pressure elevations induced by repository coritcosteroids. The duration and severity of the resulting pressure elevations were directly related to the decreasing solubility of the agent employed. Ten patitens had received intensive topical corticosteroids before injection, resulting in no intraocular pressure elevations during that period. Two patients who developed marked intraocular pressure elevations after repository corticosteroid injection did not manifest a positive response on subsequent topical corticosteroid testing.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 937460     DOI: 10.1016/0002-9394(76)90669-3

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  Triamcinolone acetonide for refractory pseudophakic cystoid macular edema after intravitreal bevacizumab.

Authors:  María Rodríguez-Blanco; Joaquin Marticorena; Francisco Gómez-Ulla
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-19       Impact factor: 3.117

2.  Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis.

Authors:  Seung Youn Jea; Ik Soo Byon; Boo Sup Oum
Journal:  Korean J Ophthalmol       Date:  2006-06

Review 3.  Corticosteroids and glaucoma risk.

Authors:  R C Tripathi; S K Parapuram; B J Tripathi; Y Zhong; K V Chalam
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

4.  Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone.

Authors:  Kazuyuki Hirooka; Fumio Shiraga; Shigeto Tanaka; Tetsuya Baba; Hiroshi Mandai
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.447

Review 5.  Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.

Authors:  Sherif A Gaballa; Uday B Kompella; Omar Elgarhy; Ali M Alqahtani; Barbara Pierscionek; Raid G Alany; Hamdy Abdelkader
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

6.  Conjunctival necrosis and scleritis following subtenon triamcinolone acetonide injection.

Authors:  Alireza Eslampour; Mojtaba Abrishami; Somaye Tafaghodi
Journal:  Iran Red Crescent Med J       Date:  2013-07-05       Impact factor: 0.611

Review 7.  Steroid-induced Glaucoma: An Avoidable Irreversible Blindness.

Authors:  Sonia Phulke; Sushmita Kaushik; Savleen Kaur; S S Pandav
Journal:  J Curr Glaucoma Pract       Date:  2017-08-05

8.  Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma.

Authors:  Jeffrey O'Callaghan; Darragh E Crosbie; Paul S Cassidy; Joseph M Sherwood; Cassandra Flügel-Koch; Elke Lütjen-Drecoll; Marian M Humphries; Ester Reina-Torres; Deborah Wallace; Anna-Sophia Kiang; Matthew Campbell; W Daniel Stamer; Darryl R Overby; Colm O'Brien; Lawrence C S Tam; Peter Humphries
Journal:  Hum Mol Genet       Date:  2017-04-01       Impact factor: 6.150

9.  Comparison between Betamethasone, Fluorometholone and Loteprednol Etabonate on intraocular pressure in patients after keratorefractive surgery.

Authors:  Saeed Shokoohi-Rad; Ramin Daneshvar; Mahsa Jafarian-Shahri; Parisa Rajaee
Journal:  J Curr Ophthalmol       Date:  2017-12-07

10.  Dexamethasone PLGA Microspheres for Sub-Tenon Administration: Influence of Sterilization and Tolerance Studies.

Authors:  Deyanira Barbosa-Alfaro; Vanessa Andrés-Guerrero; Ivan Fernandez-Bueno; María Teresa García-Gutiérrez; Esther Gil-Alegre; Irene Teresa Molina-Martínez; José Carlos Pastor-Jimeno; Rocío Herrero-Vanrell; Irene Bravo-Osuna
Journal:  Pharmaceutics       Date:  2021-02-06       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.